Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1 Interventional Results available

Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)

ClinicalTrials.gov ID: NCT02013141

Public ClinicalTrials.gov record NCT02013141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 12 Months to 17 Years

Study identification

NCT ID
NCT02013141
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
Cumberland Pharmaceuticals
Industry
Enrollment
22 participants

Conditions and interventions

Interventions

  • Telavancin Drug

Drug

Eligibility (public fields only)

Age range
12 Months to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2014
Primary completion
Feb 28, 2021
Completion
Feb 28, 2021
Last update posted
Jun 23, 2024

2014 – 2021

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Hospital of Orange County Orange California 92868
Rady Children's Hospital San Diego San Diego California 92123
Children's Mercy Hospital Kansas City Missouri 64108
Rutgers-Robert Wood Johnson Medical School New Brunswick New Jersey 08901
Rainbow Babies and Children's Hospital Cleveland Ohio 44106
Toledo Children's Hospital Toledo Ohio 43606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02013141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02013141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →